Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
Clinical trial NCT05414500 · SUSPENDED
Trial details
- NCT number
- NCT05414500
- Sponsor
- University of Alabama at Birmingham
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-01
- Primary completion
- 2027-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.